Tuesday, June 11, 2024

Send This Article to People Who Say “Ivermectin Doesn’t Work for Covid-19”

If you hear your pharmacist, physician, or academic dean parrot the malignant regurgitated trope of “Ivermectin doesn’t work for Covid” or that there is “no evidence” or “no data” to support ivermectin’s use in Covid-19, send them this meta-analysis summary and annotated bibliography of over 100 studies.

This individual had gleefully declared that my testimony had been "Community-noted" adding that "Numerous valid scientific studies have shown that ivermectin is completely ineffective" and "The promotion of Ivermectin for vaccine injury puts lives at risk." The latter statement was a sleight of hand, as I had never opined on the use of ivermectin for "Vaccine injury" at any time during my testimony or in any of my previous writings.

Although the note additionally specified that "The promotion of ivermectin for 'vaccine injury' puts lives at risk," none of those links determined that the use of ivermectin poses a safety "Risk." When prescribed correctly, ivermectin has not only been determined to be safe, but it has historically proven itself to be "Astonishingly safe."

Small 72 patient RCT of ivermectin and ivermectin + doxycycline showing faster recovery with ivermectin.

The ivermectin + doxycycline group uses only a single dose of ivermectin vs. 5 daily doses for the ivermectin group.

Ivermectin group: 12mg daily for 5 days Ivermectin + doxycycline: 12mg ivermectin single dose independent of mass, 200mg doxycycline + 100mg bid 4 days https://c19p.org/ahmed.

Details of the ivermectin group compared to other patients are not provided; however ivermectin was given to a similar percentage of patients in the mild, moderate, and severe/critical groups, suggesting that ivermectin treatment was not based on severity.

H. Carvallo, Usefulness of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19 Oct 2020, NCT04425850229 patient ivermectin prophylaxis study: 96% fewer cases. 

https://brownstone.org/articles/over-100-ivermectin-studies-a-summary/

No comments: